Preliminary Results of a Phase II Study: Paclitaxel Plus Vinorelbine in Metastatic Breast Ca Patients with Contraindications to Receive Anthracyclines

ONCOLOGY

Volumn 12, Issue 1 SUPPL.1, 1998, Pages 28-30

  Martin, Miguel ^a   Casado, Antonio ^a   Segura, Pedro Perez ^a   Carbonero, Iciar Garcia ^a   Diaz Rubio, Eduardo ^a   Lluch, Ana ^b   Garcia Conde, Javier ^b  

^a University Hospital of Madrid   (Spain)

^b University Hospital of Valencia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; NAVELBINE; PACLITAXEL;

ADULT; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; METASTASIS; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PHLEBITIS;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; VINBLASTINE;

EID: 0031915949     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Valagussa P, Bambrilla C, Bonadonna G: Chemotherapy of advanced disease in Hoogstraten B, Burn I, Bloom HJG (eds): Breast Cancer International Union Against Cancer, pp 233- 256. Springer-Verlag, Berlin, 1989.
2. Seidman AD, Tiersten A, Hudis C, et al: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 13: 2575-2581, 1995.
3. Nabolhtz JM, Gelman K, Bontenbal M, et al. Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer. J Clin Oncol 14: 1858-1867, 1996.
4. Jones S, Winer E, Vogel C, et al: Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer. J Clin Oncol 13: 2567-2574, 1995.
5. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
6. Livingston RB, Ellis GK, Gralow JR, et al: Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer. J Clin Oncol 15: 1395-1400, 1997.
7. Michelotti A, Gennari A, Salvadori B, et al: Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: A phase II study. Ann Oncol 7: 857-860, 1996.